68 related articles for article (PubMed ID: 1291124)
1. [One-year follow-up of women treated with transdermal administration of estrogen for post-castration and climacteric syndromes].
Rotta L; Matĕchová E
Cesk Gynekol; 1992 Dec; 57(9-10):479-88. PubMed ID: 1291124
[TBL] [Abstract][Full Text] [Related]
2. [Transdermal administration of estrogens in women with the postcastration and climacteric syndromes].
Rotta L; Matĕchová E
Cesk Gynekol; 1992 Sep; 57(7):336-40. PubMed ID: 1394497
[TBL] [Abstract][Full Text] [Related]
3. Estrogen replacement therapy and the estraderm transdermal system.
Youngkin EQ
Nurse Pract; 1990 May; 15(5):19-26, 31. PubMed ID: 2342664
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of the climacteric symptomatology modifications and clinical-instrumental parameters in women in physiological menopause treated with hormone replacement therapy with nomegestrol acetate and in surgical menopause treated with estrogen replacement therapy. Part I].
Savoca S; D'Agosta S; Lombardo G
Minerva Ginecol; 2007 Jun; 59(3):205-14. PubMed ID: 17576399
[TBL] [Abstract][Full Text] [Related]
5. [Effect of hormone substitution therapy on AT III in women in the climacteric].
Enzelsberger H; Heytmanek H; Kurz C; Metka M
Zentralbl Gynakol; 1991; 113(11):639-44. PubMed ID: 1656654
[TBL] [Abstract][Full Text] [Related]
6. Effect of early estrogen replacement therapy on microvascular reactivity in patients after bilateral ovarectomy.
Prázný M; Fait T; Vrablik M
Neuro Endocrinol Lett; 2007 Aug; 28(4):496-501. PubMed ID: 17693976
[TBL] [Abstract][Full Text] [Related]
7. [Subdermal implantation of estradiol 17 beta (25 mg) in hysterectomized and ovariectomized women. Effects of increased serum estradiol level and neurovegetative climacteric complaints].
Tsvetkov Ts; Tsvetkov K; Petkova U
Akush Ginekol (Sofiia); 2001; 41 Suppl 4():11-2. PubMed ID: 11519312
[No Abstract] [Full Text] [Related]
8. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels.
Pluchino N; Genazzani AD; Bernardi F; Casarosa E; Pieri M; Palumbo M; Picciarelli G; Gabbanini M; Luisi M; Genazzani AR
Gynecol Endocrinol; 2005 Mar; 20(3):144-9. PubMed ID: 16019353
[TBL] [Abstract][Full Text] [Related]
9. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
Stanosz S; Zochowska E; Safranow K; Sieja K; Stanosz M
Metabolism; 2009 Jan; 58(1):1-7. PubMed ID: 19059524
[TBL] [Abstract][Full Text] [Related]
10. [Transdermal estradiol--the possibility for replacement therapy in the postmenopause].
Rachev E
Akush Ginekol (Sofiia); 1994; 33(3):45-7. PubMed ID: 7793531
[TBL] [Abstract][Full Text] [Related]
11. [Transdermal estradiol in the prevention of the menopause-induced increase in osteoresorption].
Stĕpán J; Pospíchal J; Formánková J; Rosenová Z; Kanka J; Mensík J; Presl J; Pacovský V
Cesk Gynekol; 1989 Aug; 54(7):496-505. PubMed ID: 2805095
[TBL] [Abstract][Full Text] [Related]
12. A randomized study to compare the effectiveness, tolerability, and acceptability of two different transdermal estradiol replacement therapies. The Transdermal HRT Investigators Group.
Int J Fertil Menopausal Stud; 1993; 38(1):5-11. PubMed ID: 8485612
[TBL] [Abstract][Full Text] [Related]
13. A randomised study to compare the efficacy and safety of new 17 beta-oestradiol transdermal matrix patch with Estraderm TTS 50 in hysterectomised postmenopausal women. The Lyrelle Study Group.
al-Azzawi F; Van der Mooren MJ; Rolland R; Hirvonen E
Br J Clin Pract; 1997; 51(1):20-3, 25-6. PubMed ID: 9158267
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with transdermal estradiol in the treatment of the climacteric.
Utian WH
Minerva Endocrinol; 1989; 14(1):45-8. PubMed ID: 2543895
[TBL] [Abstract][Full Text] [Related]
15. [Low-dose estrogens in the treatment of the climacteric syndrome].
Kolarov G; Nalbanski B; Kamenov Z; Protich M; Obretsova M; Sirakov M
Akush Ginekol (Sofiia); 1998; 37(4):1-4. PubMed ID: 10360038
[TBL] [Abstract][Full Text] [Related]
16. [A transdermal therapeutic system for hormonal therapy of climacteric deficiency pictures. A multicenter study].
Kerzel C; Keller PJ
Geburtshilfe Frauenheilkd; 1987 Aug; 47(8):565-8. PubMed ID: 3653671
[TBL] [Abstract][Full Text] [Related]
17. Low-dose transdermal estradiol for symptomatic perimenopause.
Shulman LP; Harari D
Menopause; 2004; 11(1):34-9. PubMed ID: 14716180
[TBL] [Abstract][Full Text] [Related]
18. [Transdermal estrogen treatment. A placebo controlled study].
Iversen OE; Eid AB; Johannesen KH; Nyland B; Løvset T
Tidsskr Nor Laegeforen; 1991 Aug; 111(20):2544-6. PubMed ID: 1948834
[TBL] [Abstract][Full Text] [Related]
19. Effect of hormone therapy on the enteroinsular axis.
Sztefko K; Rogatko I; Milewicz T; Józef K; Tomasik PJ; Szafran Z
Menopause; 2005; 12(5):630-638. PubMed ID: 16145319
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of transdermal with oral hormone substitution: a multicenter study with a new matrix patch].
Sajtos B; Herold J; Winkler UH; Schindler AE
Zentralbl Gynakol; 1995; 117(10):524-30. PubMed ID: 7491835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]